GelMEDIX Inc. is an early-stage biotechnology company leveraging its hydrogel platform to develop ocular and regenerative therapies that can restore vision. GelMEDIX was founded after multiple years of fruitful academic collaboration between our co-founders Reza Dana (Mass. Eye And Ear, Harvard Med. School) and Nasim Annabi (UCLA).? Our proprietary photo-crosslinked hydrogels uniquely enable bioadhesion, tissue regeneration, tunable mechanics, and therapeutic loading across modalities from small molecules to cell and gene therapies. Our lead program is an integrated hydrogel cell therapy designed to restore vision for macular degeneration patients with Dry AMD and GA.
GelMEDIX的外部链接
LabCentral
US，MA，Cambridge，02139
We are extremely fortunate to have our co-founder Reza Dana on our team. Congratulations on this well deserved honor!
Very honored to have received the Harvard Ophthalmology Distinguished Research Achievement Award on June 14th. Owe it entirely to my team of student-researchers and postdocs over the years, and the amazing ecosystem of education and innovation in Boston/Cambridge.
Please take a look at our great Consulting CEO Purnanand Sarma explain the evolution of #drugdelivery from improving patient compliance to our work in #regenerativemedicine changing the way #celltherapy is developed to make tissue engineering a medical reality. We are grateful to have such an expert help us restore patients' vision
Serial Biotech Executive/Entrepreneur/Investor. President-TiE Boston, Chairman, Stalicla, SA, Consulting CEO GelMEDIX. Ex President &CEO and Board member of Immunome (NASDAQ:IMNM) and TARIS Biomedical
#drug delivery #cell therapies #gene therapy #regenerative medicine #cancer #ADC #CAR-T #Macular degeneration #GelMedix #university of Minnesota College of Pharmacy #pharmaceutics
Excited to share our novel approach to vision restoring cell therapies at the BIO International Conference this week. While current retinal cell therapy approaches suffer from procedure limiting adverse events, we have demonstrated both improved safety and retinal regeneration. Come find us at the One-to-One Partnering and our presentation on June 4 at 4 PM. #BIO #Maculardegeneration #regenerativemedicine
While current retinal cell therapies leveraging retinal pigment epithelial (RPE) cells are promising, they suffer from process limitations that lead to high adverse event rates (i.e. retinal membrane formation, retinal detachment/hemorrhage) that make them unable to improve patient vision at scale. GelMEDIX is excited to present never-before-seen data on novel approaches to RPE regeneration at the upcoming Association for Research in Vision and Ophthalmology (ARVO) and Ophthalmology Innovation Source OIS Retina conferences in Seattle. We'll share how in situ formed hydrogel scaffolds optimize RPE engraftment leading to an 8X increase in cell localization and improved cell morphology post-transplantation in porcine, as well as never-before shared data demonstrating RPE monolayer restoration in a rabbit model of GA. https://lnkd.in/e_WrdqAH
GelMEDIX转发了
???????????????? ????????! The lineup of ???????????????????? ?????????????????? for the OIS Retina Innovation Summit is here! Don't miss out on the chance to witness cutting-edge developments in retinal health and technology. ?????????????? ???????? ???????? ?????????? before tickets run out! https://lnkd.in/ecAcYeV4 Annexin Pharmaceuticals AB (publ),?Annexon Biosciences,?Eluminex Biosciences Limited,?Endogena Therapeutics, Inc.,?EyePoint Pharmaceuticals,?FELIQS,?ForwardVue Pharma,?GelMEDIX, InflammX Therapeutics,?Isarna Therapeutics GmbH,?jCyte, Inc.,?Kiora Pharmaceuticals, Inc.,?Kriya,?Nanoscope Therapeutics Inc.,?Neurotech Pharmaceuticals, Inc.,?Ocular Therapeutix, Inc.,?Oculis,?ONL Therapeutics,?Optigo Biotherapeutics,?Outlook Therapeutics, Inc.,?RevOpsis Therapeutics,?Ray Therapeutics, Inc.,?REGENXBIO Inc.,?Retinai,?Ripple Therapeutics ?,?Stealth BioTherapeutics, Stuart Therapeutics,?Tarsier Pharma #OIS #OISRetina #Ophthalmology #Innovation #Retina #Annexin #Annexon #Eluminex #Endogena #EyePoint #FELIQS #ForwardVue #GelMEDIX #InflammX #Isarna #jCyte #Kiora #Kriya #Nanoscope #Neurotech #OcularTherapeutix #Oculis #ONLTherapeutics #OptigoBiotherapeutics #OutlookTherapeutics #RevOpsis #RayTherapeutics #REGENXBIO #Retinai #RippleTherapeutics #StealthBioTherapeutics #StuartTherapeutics #TarsierPharma
Grateful to our founder Nasim Annabi for the foundational work of GelMEDIX and her continued innovation. Thank you to UCLA Henry Samueli School of Engineering and Applied Science for recognizing the importance of biomaterials research
A?UCLA?research team led by Asst. Prof.?Nasim Annabi of chemical and biomolecular engineering developed a tough tissue-adhesive hydrogel patch that clings to a wound in wet tissue surfaces within seconds and can aid in drug delivery. https://lnkd.in/gw8D5HVG
Sad to leave our friends at LabCentral 700, but so excited to contuine our journey at LabCentral 238! Thank you to everyone who has made us feel so welcomed and helped us grow from a single bench to a full team over the last three years #newlab #biotech #movingforward
So glad to welcome Emily Woo as our Co-op for the Spring 2024 Cycle from Northeastern University College of Engineering. This has been great program to take part in, and we are extremely excited to have Emily on the team to help us innovate solutions for restoring vision for patients suffering from retinal degeneration #biotech #regenerativemedicine #amd
Very excited to be speaking at the 2nd Next Generation?Ophthalmic?Drug?Delivery?Summit next week in San Francisco! I will be presenting on Developing Precise Subretinal Formulations for Cell Replacement Therapies with improved localization and engraftment rates. Looking forward to reconnecting with the Drug Delivery and Ophthalmology Communities #ophthalmology #drugdelivery #bioengineering https://ter.li/d4mn9l